Medical diagnostics

Within the healthcare industry, biological understanding is limited to an imaginary “average” cell. Even the top medical professionals in the world still lack a complete understanding of how individuals respond to treatments and how they develop diseases. As a result, medicine adopts a "one-size-fits-all" approach based on general population averages. Furthermore, diagnostics is also currently a time-consuming multi-step process. By utilizing magnetic detection rather than standard biomarker detection methods that rely on light, NV quantum sensors provide an alternative. This removes the effect of background light on results and enables more precise measurements without the requirement for sample preparation. NV quantum sensors have the potential to raise the standard of healthcare by giving clinicians more thorough and precise information about a patient's status, as well as the financial benefit of drastically cutting preparation time. By 2027, it is anticipated that the market for biomarker detection would be worth around $6.5 billion, and the incorporation of quantum sensors into point-of-care diagnostic tools may spur even faster industry expansion. By utilizing magnetic detection rather than standard biomarker detection, NV quantum sensors provide an alternative to optical methods. This removes the effect of background light on results and enables more precise measurements without the requirement for sample preparation. NV quantum sensors have the potential to raise the standard of healthcare by giving clinicians more thorough and precise information about a patient's status, as well as the financial benefit of drastically cutting preparation time.

Quantum sensing has both the sensitivity and resolution to study single cells, which was inaccessible prior, and enables better drug development.Diagnostics could be greatly accelerated by magnetic-based assays. These could include for example stroke biomarkers such as B-type Natriuretic Peptide (BNP), neuron specific enolase (NSE), fibronectin for hemorrhagic stroke, and purines (e.g., adenosine, inosine and hypoxanthine) released after stroke onset. Quantum sensing would provide medical professionals and researchers the ability to unlock the “black box” of human biology.

Imagine what is possible with non-invasive point-of-care diagnostics in developing nations! Furthermore, with personalized precision medicine, healthcare professionals can more accurately predict disease susceptibility, tailor disease-prevention strategies, avoid side effects, and do away with the inefficiencies of trial-and-error that drive up medical costs and patient care.